Categories AlphaGraphs, Earnings, Health Care

Key highlights from AngioDynamics (ANGO) Q4 2020 earnings results

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020.

  • Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019
  • Net sales decreased 41% to $58.3 million
  • Capital expenditures during the quarter was $1.5 million

Looking forward to listening to management/analysts comments on Q4 results? Stay tuned here for AngioDynamics Q4 2020 earnings call transcript

AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results

Most Popular

Oracle (ORCL) Q4 earnings, revenue beat Street view

Software giant Oracle Corporation (NYSE: ORCL) reported a 28% growth in fourth-quarter earnings, aided by an increase in revenues. The results also topped Wall Street's prediction. At $11.2 billion, revenues

Southwest Airlines (LUV): Three factors that work in favor of this airline stock

Shares of Southwest Airlines (NYSE: LUV) have gained 56% over the past 12 months and 22% since the beginning of this year. A key player in an industry that was

Lululemon’s growth story could continue in 2021

Lululemon Athletica (NASDAQ: LULU) had a very strong start to fiscal 2021. Apparently, the company is experiencing a stronger momentum in the year 2021, compared to 2019. The company surpassed

Add Comment
Viewing Highlight